Login to Your Account

If You Rebuild it, They Will Come

Venture Contraction Likely Not Over, but New Spring in Sight

By Trista Morrison

Tuesday, January 17, 2012

If there was a theme in the biotech venture capital world in 2011, it was contraction. As the year drew to a close, the industry was abuzz with reports of Prospect Venture Partners' fundraising troubles, Scale Venture Partners' and Highland Capital Partners' decisions to exit the healthcare field, personnel changes at Versant Ventures, and the merging of the life science teams at ATV and Morgenthaler Ventures.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription